MPT Regulatory Pathways: Case Studies From MPT Product Developers
The sixth webinar in the “Let’s Talk MPTs” discussion series provides the opportunity to explore the regulatory pathways and registration considerations implemented by current MPT product developers as well as insights from a leading regulatory expert in the field. Featured discussants were Mary Weitzel, MBA, of Yaso Therapeutics, Daniel Loeven, MS, from Population Council, and Wilberto Robles, MCC, MTOPRA, of WCG Cares.
View Webinar Recording
Download Presentation
Download Suggested Readings
February 2022
Click for full info +Full Info:
Resource Type:
Citation:
The sixth webinar in the “Let’s Talk MPTs” discussion series provides the opportunity to explore the regulatory pathways and registration considerations implemented by current MPT product developers as well as insights from a leading regulatory expert in the field. Featured discussants were Mary Weitzel, MBA, of Yaso Therapeutics, Daniel Loeven, MS, from Population Council, and Wilberto Robles, MCC, MTOPRA, of WCG Cares.
Authors: The IMPT, Mary Weitzel, Daniel Loeven, Wilberto Robles
Health Risks(s):
- HIV
- STI / STD
- Unintended Pregnancy
Product type(s):
- MPTs
Topic(s):
- MPTs
- Development
- Regulatory
Region(s)
- United States
- Global
Additional Keywords:
Regulatory